COVID-19 and cochleovestibular disorders: A review

Cover Page

Cite item

Full Text

Abstract

COVID-19 is an urgent problem for healthcare in various countries of the world, as it is characterized by high rates of morbidity and mortality, and is also accompanied by a wide range of complications. These include smell and taste disorders, cochleovestibular disorders and delayed neurological disorders. The purpose of this article is to describe the audiovestibular disorders associated with novel COVID-19 infection, including possible side effects of ototoxicity associated with the use of drugs used in treatment protocols for this disease.

About the authors

Andrey Yu. Ovchinnikov

Yevdokimov Moscow State University of Medicine and Dentistry

Email: lorent1@mail.ru
ORCID iD: 0000-0002-7262-1151

D. Sci. (Med.), Prof., Yevdokimov Moscow State University of Medicine and Dentistry

Russian Federation, Moscow

Nina A. Miroshnichenko

Yevdokimov Moscow State University of Medicine and Dentistry

Email: mirnino@yandex.ru
ORCID iD: 0000-0003-4213-6435

D. Sci. (Med.), Yevdokimov Moscow State University of Medicine and Dentistry

Russian Federation, Moscow

Kristina V. Savranskaya

Yevdokimov Moscow State University of Medicine and Dentistry

Email: kristina.savranskaya@gmail.com
ORCID iD: 0000-0001-8510-3719

Cand. Sci. (Med.), Yevdokimov Moscow State University of Medicine and Dentistry

Russian Federation, Moscow

Andrey A. Zaitsev

Burdenko Main Military Clinical Hospital; BIOTECH University

Author for correspondence.
Email: a-zaicev@yandex.ru
ORCID iD: 0000-0002-0934-7313
SPIN-code: 6549-5154

D. Sci. (Med.), Prof., Burdenko Main Military Clinical Hospital, BIOTECH University

Russian Federation, Moscow; Moscow

References

  1. World Health Organization WHO coronavirus disease (COVID-19) dashboard. Available at: https://COVID19.who.int/ Accessed: 14.03.2023.
  2. Centers for Disease Control and Prevention Symptoms of coronavirus Available at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed: 14.03.2023.
  3. Khoza-Shangase K. Cochleovestibular findings linked to COVID-19: A scoping review for clinical care planning in South Africa. Afr J Commun Disord. 2022;69(2):e1-12. doi: 10.4102/sajcd.v69i2.899
  4. Agyeman AA, Chin KL, Landersdorfer CB, et al. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020;95(8):1621-31. doi: 10.1016/j.mayocp.2020.05.030
  5. Jafari Z, Kolb B, Mohajerani M. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2022;49(2):184-95. doi: 10.1017/cjn.2021.63
  6. Abboud H, Abboud FZ, Kharbouch H, et al. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg. 2020;140:49-53. doi: 10.1016/j.wneu.2020.05.193.
  7. Özçelik Korkmaz M, Eğilmez OK, Özçelik MA, Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol. 2021;278(5):1675-85. doi: 10.1007/s00405-020-06396-8
  8. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. doi: 10.1001/jamaneurol.2020.1127
  9. Wilson WR. The relationship of the herpesvirus family to sudden hearing loss: a prospective clinical study and literature review. Laryngoscope. 1986;96(8):870-7. doi: 10.1002/lary.1986.96.8.870
  10. Nomura Y, Kurata T, Saito K. Cochlear changes after herpes simplex virus infection. Acta Otolaryngol. 1985;99(3-4):419-27. doi: 10.3109/00016488509108933
  11. Esaki S, Goshima F, Kimura H, et al. Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice. Acta Otolaryngol. 2011;131(7):684-91. doi: 10.3109/00016489.2010.546808
  12. Yun N, Ronca S, Tamura A, et al. Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection. J Virol. 2015;90(6):2920-7. doi: 10.1128/JVI.02948-15
  13. Cashman K, Wilkinson E, Zeng X, et al. Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques. mBio. 2018;9(5):e01896-18. doi: 10.1128/mBio.01896-18
  14. Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A note. Am J Otolaryngol. 2020;41(3):102473. doi: 10.1016/j.amjoto.2020.102473
  15. Karimi-Galougahi M, Naeini A, Raad N, et al. Vertigo and hearing loss during the COVID-19 pandemic – is there an association? Acta Otorhinolaryngol Ital. 2020;40(6):463-5. doi: 10.14639/0392-100X-N0820
  16. Jacob J, Flannery W, Mostert C. Novel ENT triad of anosmia, ageusia and hearing impairment in COVID-19. Intern Med J. 2020;50(9):1155. doi: 10.1111/imj.14880
  17. Degen C, Lenarz T, Willenborg K. Acute Profound Sensorineural Hearing Loss After COVID-19 Pneumonia. Mayo Clin Proc. 2020;95(8):1801-3. doi: 10.1016/j.mayocp.2020.05.034
  18. Chern A, Famuyide A, Moonis G, Lalwani A. Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19. Otol Neurotol. 2021;42(1):e10-4. doi: 10.1097/MAO.0000000000002860
  19. Mustafa M. Audiological profile of asymptomatic COVID-19 PCR-positive cases. Am J Otolaryngol. 2020;41:102483.
  20. Kilic O, Kalcioglu M, Cag Y, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208-11. doi: 10.1016/j.ijid.2020.06.023
  21. Viola P, Ralli M, Pisani D, et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol. 2021;278(10):3725-30. doi: 10.1007/s00405-020-06440-7
  22. Malayala S, Mohan G, Vasireddy D, Atluri P. A case series of vestibular symptoms in positive or suspected COVID-19 patients. Infez Med. 2021;29(1):117-22.
  23. Mat Q, Noël A, Loiselet L, et al. Vestibular Neuritis as Clinical Presentation of COVID-19. Ear Nose Throat J. 2021:145561321995021. doi: 10.1177/0145561321995021
  24. Beukes EW, Baguley DM, Jacquemin L, et al. Changes in Tinnitus Experiences During the COVID-19 Pandemic. Front Public Health. 2020;8:592878. doi: 10.3389/fpubh.2020.592878
  25. Bykowski A, Logan T. Cinchonism. Treasure Island (FL): StatPearls Publishing, 2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK559319/ Accessed: 14.03.2023.
  26. Saniasiaya J, Kulasegarah J. Auditory Cinchonism in COVID Era. Ear Nose Throat J. 2020;99:597-8.
  27. Ikeda A, Prince A, Chen J, et al. Macrolide-associated sensorineural hearing loss: a systematic review. Laryngoscope. 2018;128:228-36.
  28. Alsowaida Y, Almulhim A, Oh M, et al. Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association. Int J Pharm Pract. 2021;29(1):21-8. doi: 10.1111/ijpp.12670
  29. Временные методические рекомендации «Профилактика и лечение новой короновирусной инфекции (COVID-19)». Версия 16 (18.08.2022). Режим доступа: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/ВМР_COVID-19_V16.pdf. Ссылка активна на 14.03.2023 [Interim guidelines "Prevention and treatment of novel coronovirus infection (COVID-19)". Version 16 (08/18/2022). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/ВМР_COVID-19_V16.pdf. Accessed: 14.03.2023 (in Russian)].
  30. Williams B. Ototoxicity may be associated with protease inhibitor therapy. Clin Infect Dis. 2001;33:2100-2.

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies